Compass Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,771
Closed -$484K 124
2025
Q3
$484K Buy
5,771
+687
+14% +$56.6K 0.11% 109
2025
Q2
$402K Sell
5,084
-954
-16% -$75.8K 0.1% 116
2025
Q1
$542K Sell
6,038
-177
-3% -$16.5K 0.14% 103
2024
Q4
$618K Sell
6,215
-1,637
-21% -$169K 0.15% 97
2024
Q3
$892K Sell
7,852
-198
-2% -$23.5K 0.21% 84
2024
Q2
$997K Buy
8,050
+170
+2% +$21.9K 0.25% 84
2024
Q1
$1.04M Buy
7,880
+350
+5% +$43.1K 0.26% 86
2023
Q4
$821K Buy
7,530
+321
+4% +$33.3K 0.23% 92
2023
Q3
$742K Buy
7,209
+129
+2% +$13.9K 0.23% 98
2023
Q2
$817K Sell
7,080
-50
-0.7% -$5.68K 0.25% 93
2023
Q1
$759K Sell
7,130
-50
-0.7% -$5.4K 0.24% 101
2022
Q4
$797K Buy
+7,180
New +$734K 0.26% 95

Other funds holding MRK

Compass Wealth Management's MRK Position: Q4 2025 in Review

Compass Wealth Management sold out of Merck (MRK) in Q4 2025, closing a stake of 5,771 shares — an estimated $484K sold.

Compass Wealth Management first reported a position in MRK in Q4 2022 and held it in 12 quarters. The position peaked at $1.04M in Q1 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Compass Wealth Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Compass Wealth Management sold 5,771 Merck shares in Q4 2025, an estimated $484K.
  • Compass Wealth Management first reported a position in Merck in Q4 2022 and held it in 12 quarters.
  • Compass Wealth Management's Merck position peaked at $1.04M in Q1 2024.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Compass Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.